Response dependent treatment of stages IA, IIA and IIIA Hodgkin's disease with DBVE (doxorubicin/bleomycin/vincristine/etoposide) and low dose involved field irradiation with or without Zinecard: a pediatric oncology group phase III study.
Phase of Trial: Phase III
Latest Information Update: 23 Aug 2013
At a glance
- Drugs Dexrazoxane (Primary) ; Bleomycin; Doxorubicin; Etoposide; Filgrastim; Vincristine
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 16 Sep 2005 New trial record.